Literature DB >> 28948291

Very late bioresorbable vascular scaffold thrombosis at 25 months post implantation.

Koo Hui Chan1, Swee-Chong Seow1, Huay Cheem Tan1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28948291      PMCID： PMC5605831          DOI： 10.11622/smedj.2017089

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   1.858


× No keyword cloud information.
  11 in total

1.  Late Structural Discontinuity as a Possible Cause of Very Late Everolimus-Eluting Bioresorbable Scaffold Thrombosis.

Authors:  Alfonso Ielasi; Bernardo Cortese; Giuseppe Steffenino
Journal:  JACC Cardiovasc Interv       Date:  2015-08-24       Impact factor: 11.195

2.  Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.

Authors:  Patrick W Serruys; Yoshinobu Onuma; Hector M Garcia-Garcia; Takashi Muramatsu; Robert-Jan van Geuns; Bernard de Bruyne; Dariusz Dudek; Leif Thuesen; Pieter C Smits; Bernard Chevalier; Dougal McClean; Jacques Koolen; Stephan Windecker; Robert Whitbourn; Ian Meredith; Cecile Dorange; Susan Veldhof; Karine Miquel Hebert; Richard Rapoza; John A Ormiston
Journal:  EuroIntervention       Date:  2014-03-20       Impact factor: 6.534

3.  Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.

Authors:  Lorenzo Azzalini; Malek Al-Hawwas; Philippe L L'Allier
Journal:  EuroIntervention       Date:  2015-05-19       Impact factor: 6.534

4.  Very late bioresorbable vascular scaffold thrombosis following discontinuation of antiplatelet therapy.

Authors:  Leo Timmers; Pieter R Stella; Pierfrancesco Agostoni
Journal:  Eur Heart J       Date:  2014-10-21       Impact factor: 29.983

5.  Very late thrombosis observed on optical coherence tomography 22 months after the implantation of a polymer-based bioresorbable vascular scaffold.

Authors:  Takao Sato; Mohamed Abdel-Wahab; Gert Richardt
Journal:  Eur Heart J       Date:  2015-03-02       Impact factor: 29.983

6.  Very late bioresorbable vascular scaffold thrombosis due to late device recoil.

Authors:  Bernardo Cortese; Davide Piraino; Alfonso Ielasi; Giuseppe Steffenino; Pedro Silva Orrego
Journal:  Int J Cardiol       Date:  2015-04-03       Impact factor: 4.164

7.  Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.

Authors:  Davide Capodanno; Tommaso Gori; Holger Nef; Azeem Latib; Julinda Mehilli; Maciej Lesiak; Giuseppe Caramanno; Christoph Naber; Carlo Di Mario; Antonio Colombo; Piera Capranzano; Jens Wiebe; Aleksander Araszkiewicz; Salvatore Geraci; Stelios Pyxaras; Alessio Mattesini; Toru Naganuma; Thomas Münzel; Corrado Tamburino
Journal:  EuroIntervention       Date:  2015-02       Impact factor: 6.534

8.  OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.

Authors:  Antonios Karanasos; Cihan Simsek; Muthukarrupan Gnanadesigan; Nienke S van Ditzhuijzen; Raphael Freire; Jouke Dijkstra; Shengxian Tu; Nicolas Van Mieghem; Gijs van Soest; Peter de Jaegere; Patrick W Serruys; Felix Zijlstra; Robert-Jan van Geuns; Evelyn Regar
Journal:  J Am Coll Cardiol       Date:  2014-12-01       Impact factor: 24.094

Review 9.  Bioresorbable scaffolds: rationale, current status, challenges, and future.

Authors:  Javaid Iqbal; Yoshinobu Onuma; John Ormiston; Alexandre Abizaid; Ron Waksman; Patrick Serruys
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

10.  Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.

Authors:  Antonios Karanasos; Nicolas Van Mieghem; Nienke van Ditzhuijzen; Cordula Felix; Joost Daemen; Anouchska Autar; Yoshinobu Onuma; Mie Kurata; Roberto Diletti; Marco Valgimigli; Floris Kauer; Heleen van Beusekom; Peter de Jaegere; Felix Zijlstra; Robert-Jan van Geuns; Evelyn Regar
Journal:  Circ Cardiovasc Interv       Date:  2015-05       Impact factor: 6.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.